VITROME, Campus IRD-UCAD, Dakar, Senegal.
Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Économiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.
J Viral Hepat. 2021 Nov;28(11):1515-1525. doi: 10.1111/jvh.13589. Epub 2021 Aug 17.
Sub-Saharan Africa's hepatitis B virus (HBV) burden is primarily due to infection in infancy. However, data on chronic HBV infection prevalence and associated risk factors in children born post-HBV vaccination introduction are scarce. We estimated hepatitis B surface antigen (HBsAg) prevalence and risk factors in Senegalese children born during the HBV vaccination era. In 2018-2019, a community-based cross-sectional survey was conducted in Senegal among children born between 2004 and 2015 (ie after the three-dose HBV vaccine series was introduced (2004) but before the birth dose's introduction (2016)). HBsAg-positive children were identified using dried blood spots. A standardized questionnaire collected socioeconomic information. Data were age-sex weighted and calibrated to be representative of children living in the study area. Risk factors associated with HBsAg positivity were identified using negative binomial regression. Among 1,327 children, 17 were HBsAg-positive (prevalence = 1.23% (95% confidence interval [CI] 0.61-1.85)). Older age (adjusted incidence-rate ratio [aIRR] 1.31 per one-year increase, 95% CI 1.10-1.57), home vs healthcare facility delivery (aIRR 3.55, 95% CI 1.39-9.02), stitches (lifetime) (aIRR 4.79; 95% CI 1.84-12.39), tattoos (aIRR 8.97, 95% CI 1.01-79.11) and having an HBsAg-positive sibling with the same mother (aIRR 3.05, 95% CI 1.09-8.57) were all independently associated with HBsAg positivity. The low HBsAg prevalence highlights the success of the Senegalese HBV vaccination program. To further reduce HBV acquisition in children, high-risk groups, including pregnant women and siblings of HBsAg-positive individuals, must be screened. Vital HBV infection prevention measures include promoting delivery in healthcare facilities, and increasing awareness of prevention and control procedures.
撒哈拉以南非洲的乙型肝炎病毒(HBV)负担主要归因于婴儿时期的感染。然而,关于乙型肝炎疫苗接种引入后出生的儿童中慢性 HBV 感染流行率和相关危险因素的数据很少。我们评估了塞内加尔乙型肝炎疫苗接种时代出生的儿童中乙型肝炎表面抗原(HBsAg)的流行率和危险因素。2018-2019 年,在塞内加尔进行了一项基于社区的横断面调查,调查对象为 2004 年至 2015 年期间出生的儿童(即三剂乙型肝炎疫苗系列接种(2004 年)后但出生剂量接种(2016 年)前)。使用干血斑检测 HBsAg 阳性儿童。标准化问卷收集社会经济信息。数据按年龄和性别加权,并进行校准以代表研究区域内的儿童。使用负二项回归确定与 HBsAg 阳性相关的危险因素。在 1327 名儿童中,有 17 名 HBsAg 阳性(流行率为 1.23%(95%置信区间 [CI] 0.61-1.85))。年龄较大(调整后发病率比 [aIRR] 每增加一岁增加 1.31,95%CI 1.10-1.57)、家庭分娩与医疗保健机构分娩(aIRR 3.55,95%CI 1.39-9.02)、缝线(终生)(aIRR 4.79;95%CI 1.84-12.39)、纹身(aIRR 8.97,95%CI 1.01-79.11)和具有相同母亲的 HBsAg 阳性兄弟姐妹(aIRR 3.05,95%CI 1.09-8.57)均与 HBsAg 阳性独立相关。低 HBsAg 流行率突出了塞内加尔乙型肝炎疫苗接种计划的成功。为了进一步减少儿童乙型肝炎的获得,必须对包括孕妇和 HBsAg 阳性个体的兄弟姐妹在内的高危人群进行筛查。乙型肝炎病毒感染的重要预防措施包括促进在医疗保健机构分娩,以及提高对预防和控制程序的认识。